Gilead licenses generic H.I.V. prevention injection for lower-income nations
Gilead Sciences, a major pharmaceutical company, recently unveiled a major initiative to fight HIV globally by enabling the production of a generic version of its breakthrough drug, lenacapavir. This injectable…